Hot Features
Premium
Level up your trading with our powerful tools and real-time insights all in one place.
Period:
Draw Mode:
| Volume | 20,534 |
|
|||||
| News | - | ||||||
| Day High | 2.24 | Low High |
|||||
| Day Low | 2.09 | ||||||
| Share Name | Share Symbol | Market | Stock Type |
|---|---|---|---|
| BriaCell Therapeutics Corporation | BCTX | NASDAQ | Common Stock |
| Price Change | Price Change % | Share Price | Last Trade
|
|
|---|---|---|---|---|
| 0.13 | 6.16% | 2.24 | 15:31:06 |
| Open Price | Low Price | High Price | Close Price | Previous Close |
|---|---|---|---|---|
| 2.16 | 2.09 | 2.24 | 2.24 | 2.11 |
| Trades | Shares Traded | VWAP | Financial Volume | Average Volume | 52 Week Range |
|---|---|---|---|---|---|
| 201 | 20,534 | US$ 2.17 | US$ 44,613 | - | 2.01 - 7.59 |
| Last Trade | Type | Quantity | Price | Currency |
|---|---|---|---|---|
| 15:01:11 | 9 | US$ 2.25 | USD |
BriaCell Therapeutics Corporation Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 169.41M | 15.98M | - | 0 | -20.3M | -1.27 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
BriaCell Therapeutics News
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical BCTX Price Data
| Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 2.15 | 2.29 | 2.0558 | 2.18 | 28,084 | 0.09 | 4.19% |
| 1 Month | 2.88 | 3.03 | 2.01 | 2.45 | 44,277 | -0.64 | -22.22% |
| 3 Months | 4.00 | 4.03 | 2.01 | 2.88 | 77,913 | -1.76 | -44.00% |
| 6 Months | 3.90 | 5.97 | 2.01 | 3.90 | 92,963 | -1.66 | -42.56% |
| 1 Year | 7.15 | 7.59 | 2.01 | 5.08 | 95,646 | -4.91 | -68.67% |
| 3 Years | 3.90 | 12.47 | 2.01 | 6.87 | 861,321 | -1.66 | -42.56% |
| 5 Years | 4.24 | 12.47 | 2.01 | 6.60 | 891,124 | -2.00 | -47.17% |
BriaCell Therapeutics Description
| BriaCell Therapeutics Corp is an immuno-oncology focused biotechnology company developing targeted and safe approaches for the management of cancer. BriaCell, in collaboration with Incyte Corp., is conducting a Phase I/IIa clinical trial of Bria-IMT, its lead candidate, in a Combination Study with Incyte drugs, INCMGA00012, and epacadostat, in advanced breast cancer. Additionally, it is developing Bria-OTS, off-the-shelf personalized immunotherapy, for advanced breast cancer. Bria-OTS immunotherapy treatments are personalized to match the patient without the need for personalized manufacturing and is designed to produce a potent and selective immune response against the cancer of each patient eliminating the time, expense and complex manufacturing logistics associated with immunotherapies. |
